Despite Netflix's continued success, its stock has declined by 32% from its mid-2025 peak. However, it's still up 84,837% ...

While the Berkshire Hathaway portfolio totals approximately $300 billion today, Wechsler will have significantly more money ...

Priced at $4.2 million per unit currently, PAC-3 MSE is a $2.5 billion franchise for Lockheed Martin at present. Although it ...

Nvidia has been, without a doubt, one of the best-performing stocks. Shares have climbed 1,320% in the past five years (as of ...

In December, President Donald Trump decided to permit Nvidia to sell its advanced H200 chips to some Chinese customers. A ...

Nebius stock fell in the days after Oracle's earnings report, losing 19% over a week. Oracle dropped as the company missed ...

NuScale stock is up about 37% in the brand-new year, helped by the Trump administration's recent award of $2.7 billion to three uranium enrichment companies. NuScale wasn't one of the recipients, but ...

This home-based care provider reported notable insider selling as its shares marked strong gains over the past year.

If the treatment wins FDA approval, its success will depend on pricing. Vera's rival, Otsuka Pharmaceutical, which earned an ...

Rigetti's stock has been red-hot in the past two years as investors have been feeling bullish on the future for quantum ...

However, Palantir's huge gains have left the stock at a huge valuation; it's trading at a forward price-to-sales (P/S) ...

If you're looking for a fund to help mitigate portfolio volatility during uncertain times yet still provide exposure to the ...